Business Segments Kamada Ltd.

Stocks

KMDA

IL0010941198

Pharmaceuticals

Delayed TEL AVIV STOCK EXCHANGE Other stock markets 10:28:56 2026-07-22 EDT			5-day change	1st Jan Change
2,173.00 ^ILa	-1.27%		+1.02%	-3.85%

07-20	Kamada Ltd Announces Three-Year USD 50 Million Supply Agreement To Supply Plasma To Biopharmaceutical Company Focused On Plasma-Derived Therapies	CI
07-20	Kamada Signs $50 Million Plasma Supply Agreement With Biopharmaceutical Firm	MT

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Gross Profit: Breakdown by Business Segment

Breakdown by Business Segment (USD)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Biological Products
Proprietary Products						75.52M	103M	115M	141M	156M
Gross Profit						27.33M	44.37M	52.12M	67.74M	72.28M
Pharmaceutical Product Distribution
Distribution						28.12M	26.74M	27.06M	19.51M	24.25M
Gross Profit						3M	2.33M	3.37M	2.23M	4.13M

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
U.S.A						-	-	73.74M	101M	99.64M
Israel						35.77M	32.03M	31.3M	25.01M	29.56M
Latin America						9.13M	11.29M	12.93M	18.61M	24.22M
Canada						-	-	11.16M	9.46M	10.8M
Europe						5.68M	5.28M	7.09M	4.94M	9.45M
Asia						3.17M	4.58M	6.15M	2.38M	6.72M
Others						134K	305K	157K	62K	56K
U.S.A and North America						49.76M	75.85M	-	-	-

The best tools reserved for subscribers to boost the performance of your investments!

×